You are here

Editor & Authors

Patrick A. Flume, MD (Guest Editor)
Medical University of South Carolina, Charleston, SC, USA

Prof. Manfred Ballmann
Klinikum der Ruhr-Universit¨at, Kinderklinik, Bochum, Germany

David Geller, MD
Nemours Children’s Clinic, Orlando, FL, USA

David Lo, MB ChB MRCPCH
Nottingham City Hospital, Nottingham, UK

Susan Madge, SRN RSCN MSc MCGI PhD
Royal Brompton Hospital, London, UK

Alan Smyth, MA MBBS MCRP MD FRCPCH
Nottingham City Hospital, Nottingham, UK

Donald R. VanDevanter, PhD
Case Western Reserve University School of Medicine, Cleveland, OH, USA

Presented by the Medical University of South Carolina in collaboration with DKBmed.
Supported by an Educational Grant from Gilead Sciences, Inc.

 

Disclosure Information

In accordance with the ACCME Essentials and Standards, anyone involved in planning or presenting this enduring material is required to disclose any relevant financial relationships with commercial interests in the healthcare industry. This information is listed below.

The Medical University of South Carolina, as an ACCME provider, requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The Medical University of South Carolina recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.

Planners and authors with no relevant financial relationships:

David Lo, MB ChB MRCPCH

Planners and authors with relevant financial relationships:

Patrick A. Flume, MD – Research Grants: Bayer Healthcare AG, Boehringer Ingelheim Pharmaceuticals, Gilead Sciences, Inc., Inspire Pharmaceuticals, Inc., Mpex Pharmaceuticals, Inc., Novartis, Pharmaxis Limited, Vertex Pharmaceuticals, Inc., Cystic Fibrosis Foundation, National Institutes of Health; Consultant: Gilead Sciences, Inc., Inspire Pharmaceuticals, Inc.; Speakers Bureau: AstraZeneca.

Manfred Ballmann, MD – Consultant: Nordmark Werke; Advisory Committee/Board: Bayer Healthcare AG, Gilead Sciences, Inc., Insmed Inc., Novartis, Vertex Pharmaceuticals, Inc.

David Geller, MD – Research Grants: Aires Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Gilead Sciences, Inc., Insmed Inc., MicroDose Therapeutx, Mpex Pharmaceuticals, Inc., Novartis, Philips Respironics, Vertex Pharmaceuticals, Inc.; Speakers Bureau: Gilead Sciences, Inc.; Advisory Committee/Board: Gilead Sciences, Inc., Mpex Pharmaceuticals, Inc., Novartis.

Susan Madge, SRN, RSCN, MSc, MCGI, PhD – Advisory Committee/Board: Gilead Sciences, Inc.

Alan Smyth, MA MBBS MCRP MD FRCPCH – Advisory Committee/Board: Mpex Pharmaceuticals, Inc.; Other honoraria: Forest Pharmaceuticals, Inc.

Donald R. VanDevanter, PhD – Consultant: Baxter International Inc., Genentech, Gilead Sciences, Inc., KaloBios Pharmaceuticals, Inc., Mpex Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc.

Search form

Video Patrick A. Flume

Flume REV03 H264

Video Donald R. VanDevanter

VanDevan REV03 H264

Share